• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    46 Stocks Moving In Thursday's Mid-Day Session

    1/27/22 12:11:12 PM ET
    $ARAY
    $BLL
    $BSFC
    $CCAC
    Medical/Dental Instruments
    Health Care
    Containers/Packaging
    Consumer Durables
    Get the next $ARAY alert in real time by email

    Gainers

    • Indonesia Energy Corporation Limited (NASDAQ:INDO) shares jumped 158.2% to $7.23 after tumbling 18% on Wednesday. Indonesia Energy said it projects to commence drilling of 2 back-to-back new wells within 30 days and a third by mid-year.
    • The National Security Group, Inc. (NASDAQ:NSEC) shares jumped 73.2% to $15.59 after VR Insurance announced acquisition of the company.
    • Save Foods, Inc. (NASDAQ:SVFD) surged 27% to $4.58 after the company said it is extending the range of applications of its eco crop protection treatment after successfully applying it to fresh berries in a recent trial.
    • Seagate Technology Holdings plc (NASDAQ:STX) gained 18.5% to $114.08 after the company reported better-than-expected Q2 results and issued guidance.
    • Marine Petroleum Trust (NASDAQ:MARPS) jumped 18.1% to $5.21.
    • Galapagos NV (NASDAQ:GLPG) shares gained 18% to $62.94. Galapagos announced the appointment of Dr. Paul Stoffels as chief executive officer, effective April 1, 2022. Previously, Stoffels was vice chairman of the executive committee and chief scientific officer of Johnson & Johnson, where he spearheaded the company's research and product pipeline.
    • SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) gained 17.3% to $5.96. China's National Medical Products Administration (NMPA) signed off SELLAS Life Sciences Group’s IND application to initiate the first clinical trial for 3D189 in patients with hematological malignancies.
    • New Concept Energy, Inc. (NYSE:GBR) rose 17% to $3.0320.
    • Farmmi, Inc. (NASDAQ:FAMI) shares gained 14.7% to $0.2269. Farmmi reported FY21 sales of $39.29 million up from $28.36 million in the year-ago period.
    • LSI Industries Inc. (NASDAQ:LYTS) jumped 13.2% to $6.79 following upbeat Q2 earnings.
    • ServiceNow, Inc. (NYSE:NOW) rose 12.5% to $544.74 after the company reported better-than-expected Q4 results.
    • Dogness (International) Corporation (NASDAQ:DOGZ) gained 12.3% to $3.8850.
    • DouYu International Holdings Limited (NASDAQ:DOYU) rose 12% to $2.4750. Tencent Holdings is looking to take DouYu International private by 2022 end amid disagreements over strategy among executives at the Chinese videogame streaming firm, Reuters reported.
    • Mechel PAO (NYSE:MTL) rose 11.6% to $2.80 after declining around 5% on Wednesday.
    • Levi Strauss & Co. (NYSE:LEVI) rose 10.2% to $22.40 after the company reported Q4 results and issued FY22 forecast.
    • TSR, Inc. (NASDAQ:TSRI) gained 10% to $13.09.
    • Qualtrics International Inc. (NASDAQ:XM) rose 9.7% to $26.60 after the company reported better-than-expected Q4 sales results and issued guidance.
    • Immix Biopharma, Inc. (NASDAQ:IMMX) gained 9.3% to $3.88. Immix Biopharma’s IMX-110 + anti-PD-1 produced 63-day median survival in a genetic pancreatic cancer mouse model, in which mice develop their own pancreatic cancer and have an intact immune system.
    • Packaging Corporation of America (NYSE:PKG) surged 9.2% to $145.68. Packaging Corp Of America reported fourth-quarter FY21 sales growth of 19% year-on-year, to $2.04 billion, beating the analyst consensus of $1.94 billion.
    • Celestica Inc. (NYSE:CLS) gained 7.6% to $11.80 following upbeat Q4 results.
    • Ball Corporation (NYSE:BLL) gained 6.6% to $92.26 after reporting better-than-expected quarterly results.
    • Mainz Biomed B.V. (NASDAQ:MYNZ) rose 5.7% to $15.32. Mainz Biomed shares dipped 28% on Wednesday after the company priced a 1.5 million share follow-on offering at $15 per share.
    • Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) rose 5% to $6.73. Baird initiated coverage on Reneo Pharmaceuticals with an Outperform rating and announced price target of $28.

    Check out these penny stocks insiders are buying

    Losers

    • Epizyme, Inc. (NASDAQ:EPZM) shares fell 36.1% to $1.2150 after the company priced an underwritten public offering of 56,666,667 shares at $1.50 per share, before underwriting discounts.
    • 1-800-FLOWERS.COM, Inc. (NASDAQ:FLWS) shares dipped 31% to $14.60 after the company reported worse-than-expected Q2 EPS and sales results. 1-800-Flowers sees FY22 revenue growth of 7% - 9%.
    • Teradyne, Inc. (NASDAQ:TER) fell 28% to $103.38 after the company issued Q1 EPS and sales guidance below estimates.
    • LendingClub Corporation (NYSE:LC) fell 25.4% to $16.78 after the company reported Q4 earnings results and issued Q1 and FY22 sales guidance. Credit Suisse maintained LendingClub with a Neutral and lowered the price target from $34 to $27.
    • Merida Merger Corp. I (NASDAQ:MCMJ) dropped 23.6% to $7.63.
    • Blue Star Foods Corp. (NASDAQ:BSFC) fell 22.7% to $2.93. Blue Star Foods recently said it will receive $5 million investment from The Lind Partners.
    • TG Therapeutics, Inc. (NASDAQ:TGTX) fell 22% to $10.83. TG Therapeutics said the FDA imposed partial clinical hold on select studies of U2 and its components for CLL and NHL.
    • Cue Biopharma, Inc. (NASDAQ:CUE) dropped 20.4% to $8.44. Cue Biopharma said early data from the Phase 1 combination study of CUE-101 and Merck & Co., supported synergistic activity, with two of the four patients treated in dose escalation in two cohosts showing partial responses.
    • Ivanhoe Capital Acquisition Corp. (NYSE:IVAN) dropped 19.1% to $8.07.
    • Accuray Incorporated (NASDAQ:ARAY) fell 15.6% to $3.4350 following Q2 results.
    • Ebang International Holdings Inc. (NASDAQ:EBON) fell 14.3% to $0.9343 after jumping 35% on Wednesday.
    • Weidai Ltd. (NYSE:WEI) fell 13.7% to $2.0177.
    • Yoshitsu Co., Ltd (NASDAQ:TKLF) dropped 13.7% to $2.81.
    • CITIC Capital Acquisition Corp. (NYSE:CCAC) declined 12.1% to $8.72.
    • Unifi, Inc. (NYSE:UFI) fell 11.5% to $19.86 following Q2 earnings.
    • Pear Therapeutics, Inc. (NASDAQ:PEAR) dropped 11.3% to $3.69. B of A Securities recently initiated coverage on Pear Therapeutics with a Neutral rating and announced a price target of $5.
    • Watts Water Technologies, Inc. (NYSE:WTS) fell 10.3% to $152.33. Watts Water Technologies will replace Sterling Bancorp/DE in the S&P MidCap 400.
    • Tesla, Inc. (NASDAQ:TSLA) fell 7.9% to $863.56. Tesla reported better-than-expected earnings and sales results for its fourth quarter. The company produced 305,840 vehicles in the fourth quarter, up 70% year-over-year. A total of 308,650 vehicles were delivered in the fourth quarter, up 71% year-over-year.
    • Haemonetics Corporation (NYSE:HAE) dropped 7.7% to $43.75. Needham downgraded Haemonetics from Buy to Hold.
    • LG Display Co., Ltd. (NYSE:LPL) fell 7.5% to $8.14. LG Display recently reported fourth-quarter FY21 revenue growth of 18% year-on-year to KRW 8.81 trillion.
    • Intel Corporation (NASDAQ:INTC) dipped 7.1% to $48.01 after the company issued Q1 EPS guidance below estimates.
    • SAP SE (NYSE:SAP) fell 6.7% to $123.43. SAP reported fourth-quarter FY21 revenue growth of 3% year-on-year to €7.98 billion at constant currencies and announced plans to acquire a majority stake of Taulia, a leading provider of working capital management solutions.
    • Zymeworks Inc. (NASDAQ:ZYME) shares fell 5.6% to $8.81 after the company reported pricing of $100.0 million public offering.

    Also check out insider selling in big stocks

    Get the next $ARAY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ARAY
    $BLL
    $BSFC
    $CCAC

    CompanyDatePrice TargetRatingAnalyst
    Intel Corporation
    $INTC
    4/24/2026$60.00 → $80.00Hold
    Jefferies
    Intel Corporation
    $INTC
    4/24/2026$48.00 → $56.00Underperform
    BofA Securities
    Intel Corporation
    $INTC
    4/24/2026$50.00 → $75.00Neutral
    Robert W. Baird
    Intel Corporation
    $INTC
    4/24/2026$35.00 → $45.00Underweight
    Analyst
    Intel Corporation
    $INTC
    4/24/2026$70.00 → $110.00Overweight
    KeyBanc Capital Markets
    Intel Corporation
    $INTC
    4/24/2026$65.00 → $75.00Hold
    Stifel
    Intel Corporation
    $INTC
    4/24/2026$76.00 → $105.00Buy
    The Benchmark Company
    Intel Corporation
    $INTC
    4/24/2026$48.00 → $80.00Sector Perform
    RBC Capital Mkts
    More analyst ratings

    $ARAY
    $BLL
    $BSFC
    $CCAC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP & CLO Lee James Ci converted options into 1,237 units of Ordinary Shares and covered exercise/tax liability with 540 units of Ordinary Shares, increasing direct ownership by 215% to 1,021 units (SEC Form 4)

    4 - Seagate Technology Holdings plc (0001137789) (Issuer)

    4/23/26 4:54:49 PM ET
    $STX
    Electronic Components
    Technology

    CEO Musk Elon returned 96,000,000 shares to the company, decreasing direct ownership by 18% to 423,743,904 units (SEC Form 4)

    4 - Tesla, Inc. (0001318605) (Issuer)

    4/23/26 4:05:10 PM ET
    $TSLA
    Auto Manufacturing
    Industrials

    SEC Form 4 filed by Fund 1 Investments, Llc

    4 - 1 800 FLOWERS COM INC (0001084869) (Issuer)

    4/22/26 5:26:57 PM ET
    $FLWS
    Other Specialty Stores
    Consumer Discretionary

    $ARAY
    $BLL
    $BSFC
    $CCAC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Tradr Launches Leveraged ETFs on AXTI, CPNG, MPWR and STX

    Listings cover stocks involved in trending themes such as data storage and AI compute infrastructure Tradr ETFs, a provider of ETFs designed for sophisticated investors and professional traders, today launched four new leveraged ETFs on single stocks. The Cboe-listed funds seek to deliver two times long (200%) the daily performance of a specific underlying stock. Three of the four ETFs are first-to-market strategies. The following ETFs are expected to open for trading today: Tradr 2X Long AXTI Daily ETF (Cboe: AXTX) – tracks AXT Inc. (NASDAQ:AXTI) Tradr 2X Long CPNG Daily ETF (Cboe: CPNX) – tracks Coupang Inc. (NYSE:CPNG) Tradr 2X Long MPWR Daily ETF (Cboe: MPWX) – tracks Monol

    4/24/26 6:46:00 AM ET
    $AXTI
    $CPNG
    $MPWR
    Semiconductors
    Technology
    Catalog/Specialty Distribution
    Consumer Discretionary

    New Study Highlights Safety and Efficacy Profile of Haemonetics' VASCADE MVP® XL in Large-Bore Venous Access Closure Procedures

    BOSTON, April 24, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today announced the publication of a new study comparing its VASCADE MVP® XL vascular closure system with the VASCADE MVP® venous vascular closure system in the context of large‐bore venous access closure procedures. This study, "VASCADE MVP-XL Versus VASCADE MVP for Large-Bore Venous Access-Site Closure in Electrophysiology Procedures: A Single-Center Experience on Efficacy and Complications," was published earlier this week in the Journal of Cardiovascular Electrophysiology.The retrospective, non‐rand

    4/24/26 6:20:00 AM ET
    $HAE
    Medical/Dental Instruments
    Health Care

    SAP Quarterly Statement Q1 2026

    WALLDORF, Germany, April 23, 2026 /PRNewswire/ -- SAP SE (NYSE:SAP) announced today its financial results for the first quarter ended March 31, 2026. Current cloud backlog of €21.9 billion, up 20% and up 25% at constant currenciesCloud revenue up 19% and up 27% at constant currenciesCloud ERP Suite revenue up 23% and up 30% at constant currenciesTotal revenue up 6% and up 12% at constant currenciesIFRS operating profit up 17%, non-IFRS operating profit up 17% and up 24% at constant currenciesChristian Klein, CEO:We had a strong start to the year, with Current Cloud Backlog growi

    4/23/26 4:18:00 PM ET
    $SAP
    Computer Software: Prepackaged Software
    Technology

    $ARAY
    $BLL
    $BSFC
    $CCAC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Jefferies reiterated coverage on Intel with a new price target

    Jefferies reiterated coverage of Intel with a rating of Hold and set a new price target of $80.00 from $60.00 previously

    4/24/26 10:40:55 AM ET
    $INTC
    Semiconductors
    Technology

    BofA Securities reiterated coverage on Intel with a new price target

    BofA Securities reiterated coverage of Intel with a rating of Underperform and set a new price target of $56.00 from $48.00 previously

    4/24/26 10:40:34 AM ET
    $INTC
    Semiconductors
    Technology

    Robert W. Baird reiterated coverage on Intel with a new price target

    Robert W. Baird reiterated coverage of Intel with a rating of Neutral and set a new price target of $75.00 from $50.00 previously

    4/24/26 10:40:23 AM ET
    $INTC
    Semiconductors
    Technology

    $ARAY
    $BLL
    $BSFC
    $CCAC
    SEC Filings

    View All

    SEC Form 10-Q filed by Intel Corporation

    10-Q - INTEL CORP (0000050863) (Filer)

    4/23/26 6:49:27 PM ET
    $INTC
    Semiconductors
    Technology

    SEC Form IRANNOTICE filed by Intel Corporation

    IRANNOTICE - INTEL CORP (0000050863) (Filer)

    4/23/26 7:08:42 PM ET
    $INTC
    Semiconductors
    Technology

    SEC Form DEFA14A filed by SELLAS Life Sciences Group Inc.

    DEFA14A - SELLAS Life Sciences Group, Inc. (0001390478) (Filer)

    4/23/26 4:10:13 PM ET
    $SLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ARAY
    $BLL
    $BSFC
    $CCAC
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for BRIUMVI issued to TG THERAPEUTICS, INC

    Submission status for TG THERAPEUTICS, INC's drug BRIUMVI (SUPPL-11) with active ingredient UBLITUXIMAB-XIIY has changed to 'Approval' on 10/30/2024. Application Category: BLA, Application Number: 761238, Application Classification:

    10/31/24 4:38:40 AM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for TAZVERIK issued to EPIZYME INC

    Submission status for EPIZYME INC's drug TAZVERIK (SUPPL-5) with active ingredient TAZEMETOSTAT HYDROBROMIDE has changed to 'Approval' on 08/13/2024. Application Category: NDA, Application Number: 211723, Application Classification: Labeling

    8/14/24 4:43:30 AM ET
    $EPZM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for TAZVERIK issued to EPIZYME INC

    Submission status for EPIZYME INC's drug TAZVERIK (SUPPL-4) with active ingredient TAZEMETOSTAT HYDROBROMIDE has changed to 'Approval' on 11/16/2023. Application Category: NDA, Application Number: 211723, Application Classification: Labeling

    11/17/23 4:37:35 AM ET
    $EPZM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ARAY
    $BLL
    $BSFC
    $CCAC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman & CEO Mcdermott William R bought $3,000,058 worth of shares (28,682 units at $104.60), increasing direct ownership by 22% to 158,234 units (SEC Form 4)

    4 - ServiceNow, Inc. (0001373715) (Issuer)

    3/2/26 4:11:03 PM ET
    $NOW
    Computer Software: Prepackaged Software
    Technology

    Director Mayer Steven F bought $30,878 worth of shares (54,875 units at $0.56), increasing direct ownership by 4% to 1,545,620 units (SEC Form 4)

    4 - ACCURAY INC (0001138723) (Issuer)

    2/23/26 4:10:08 PM ET
    $ARAY
    Medical/Dental Instruments
    Health Care

    Director Mayer Steven F bought $103,797 worth of shares (195,125 units at $0.53), increasing direct ownership by 15% to 1,490,745 units (SEC Form 4)

    4 - ACCURAY INC (0001138723) (Issuer)

    2/20/26 4:10:06 PM ET
    $ARAY
    Medical/Dental Instruments
    Health Care

    $ARAY
    $BLL
    $BSFC
    $CCAC
    Leadership Updates

    Live Leadership Updates

    View All

    The NHL, SAP and HEC Montréal unveil a free game powered by real hockey data - Developing Students' Analytical Skills

    MONTREAL, April 15, 2026 /CNW/ - To help prepare students from all disciplines for the analytical skills increasingly sought after in the job market, the National Hockey League (NHL), SAP and HEC Montréal are unveiling a free game powered by real professional hockey data: "The Hockey Analyst." Developed by the ERPsim Lab team at HEC Montréal under the direction of Professor Pierre–Majorique Léger, the game is designed to equip higher–education teaching staff around the world. It offers students an immersive and intuitive learning experience that helps them naturally acquire skills expected in today's professional environments, such as data interpretation and visualization, decision–making, a

    4/15/26 6:03:00 AM ET
    $SAP
    Computer Software: Prepackaged Software
    Technology

    Zymeworks Announces Additional Leadership Appointments to Advance Next Phase of Growth

    • Adam Schayowitz, Ph.D., MBA appointed as Head of R&D• Scott Platshon appointed as Chief Business Officer  VANCOUVER, British Columbia, April 09, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (NASDAQ:ZYME), a biotechnology company managing a portfolio of licensed healthcare assets, while developing a diverse pipeline of novel, multifunctional biotherapeutics, today announced the full-time appointments of Dr. Adam Schayowitz and Mr. Scott Platshon as of April 9, 2026, from their previously interim roles. Both Dr. Schayowitz and Mr. Platshon will report directly to Kenneth Galbraith, Chair and Chief Executive Officer of Zymeworks. "These appointments come at a pivotal time for Zymeworks as we e

    4/9/26 6:00:00 AM ET
    $ZYME
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Accuray Appoints Paul Miele as Senior Vice President and Chief Commercial Officer

    MADISON, Wis., April 6, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ:ARAY), a leading provider of radiation therapy systems for cancer treatment, today announced the appointment of Paul Miele as Senior Vice President and Chief Commercial Officer, effective April 6, 2026. Miele will join Accuray's executive leadership team and lead the company's global commercial organization as Accuray continues to advance its transformation and strengthen execution across its portfolio. "Paul brings deep global commercial leadership experience and a strong track record of driving transform

    4/6/26 9:00:00 AM ET
    $ARAY
    Medical/Dental Instruments
    Health Care

    $ARAY
    $BLL
    $BSFC
    $CCAC
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at Immix Biopharma Inc. on Jun 5

    Recent insider purchases at Immix Biopharma Inc. have caught the attention of investors, with Morris Gabriel S leading the way by acquiring $5,973 worth of shares on June 5, 2024. This transaction involved 3,300 units at a price of $1.81 per share, increasing Gabriel's direct ownership by 1% to 283,334 units, as reported in SEC Form 4. This move indicates Gabriel's confidence in the company's potential and may be seen as a positive signal by market participants. Click here for more details. Looking back at previous insider transactions, we can identify a few interesting patterns. On May 15, 2024, Rachman Ilya M purchased $9,660 worth of shares, comprising 4,300 units at $2.25 per share, whi

    6/10/24 1:09:24 AM ET
    $IMMX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ARAY
    $BLL
    $BSFC
    $CCAC
    Financials

    Live finance-specific insights

    View All

    SAP Quarterly Statement Q1 2026

    WALLDORF, Germany, April 23, 2026 /PRNewswire/ -- SAP SE (NYSE:SAP) announced today its financial results for the first quarter ended March 31, 2026. Current cloud backlog of €21.9 billion, up 20% and up 25% at constant currenciesCloud revenue up 19% and up 27% at constant currenciesCloud ERP Suite revenue up 23% and up 30% at constant currenciesTotal revenue up 6% and up 12% at constant currenciesIFRS operating profit up 17%, non-IFRS operating profit up 17% and up 24% at constant currenciesChristian Klein, CEO:We had a strong start to the year, with Current Cloud Backlog growi

    4/23/26 4:18:00 PM ET
    $SAP
    Computer Software: Prepackaged Software
    Technology

    Mobileye Releases First Quarter 2026 Results, Updates Full-Year Outlook, and Announces a $250 Million Share Repurchase Program

    Revenue of $558 million in the first quarter increased 27% year over year compared to Q1 2025. We are raising the midpoint of our full-year 2026 revenue guidance by 2% to reflect better-than-expected demand in the first quarter. Diluted EPS (GAAP) was $(4.68) and Adjusted Diluted EPS (Non-GAAP) was $0.12 in the first quarter. GAAP Operating Loss was impacted by a non-cash goodwill impairment of $3,788 million related to the goodwill asset on Mobileye's balance sheet resulting from Intel's acquisition of Mobileye in 2017. Generated $75 million of operating cash flow in the first quarter of 2026. The acquisition of Mentee Robotics Ltd. ("Mentee Robotics") closed in early February, r

    4/23/26 7:15:00 AM ET
    $INTC
    $MBLY
    Semiconductors
    Technology
    Computer Software: Prepackaged Software

    Mobileye Announces Share Repurchase Program of Up to $250 Million

    Mobileye Global Inc. (NASDAQ:MBLY) today announced its Board of Directors has authorized a program to repurchase up to $250 million of Mobileye's outstanding Class A common stock (the "Repurchase Program"). The share repurchase program demonstrates both the leadership team and Board of Directors' confidence in the Company's current products as well as its position as a leader in the development and deployment of advanced driver assistance systems, autonomous driving solutions, and complex physical AI systems at scale. The Repurchase Program is intended to partially offset dilution associated with share-based compensation and shares issued in connection with the Mentee Robotics acquisition

    4/23/26 6:15:00 AM ET
    $INTC
    $MBLY
    Semiconductors
    Technology
    Computer Software: Prepackaged Software

    $ARAY
    $BLL
    $BSFC
    $CCAC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Zymeworks Inc.

    SC 13G/A - Zymeworks Inc. (0001937653) (Subject)

    11/14/24 9:00:57 PM ET
    $ZYME
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by TG Therapeutics Inc.

    SC 13G/A - TG THERAPEUTICS, INC. (0001001316) (Subject)

    11/14/24 7:45:34 PM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Blue Star Foods Corp.

    SC 13G/A - Blue Star Foods Corp. (0001730773) (Subject)

    11/14/24 7:34:10 PM ET
    $BSFC